Free alpha‐subunits of human chorionic gonadotropin in preeclampsia

Authors:

Abstract
Objective: To investigate free α‐human chorionic gonadotropin (hCG) as a marker of preeclampsia. Methods: Four groups of patients were studied: normal pregnancies, preeclampsia, eclampsia and normal pregnant women < 20 weeks' gestation. Patients were further divided according to parity and gestational age (≤20, 21–30, 31–40 weeks). An immunoradiometric assay employing monoclonal antibodies specific for free α‐hCG was used. Results: A total of 313 patients were analyzed. Thirty‐four patients ≤20 weeks' gestation were followed until delivery: five (14.7%) developed preeclampsia; none had abnormal α‐hCG levels before onset of preeclampsia. Patients with preeclampsia (21–30 weeks' gestation) demonstrated a mean α‐hCG level greater than that of normotensive controls but this was not statistically significant. Between 31 and 40 weeks' gestation, mean α‐hCG levels in the hypertensive and control groups were 210.8 ng/ml and 115.8 ng/ml, respectively (P < 0.001). A stronger association was observed between α‐hCG and preeclampsia with increasing gestational age (relative risk [RR]2.07, 21–30 weeks; RR 3.02, 31–40 weeks) and severity (RR 4.51, mild; RR 12.15, severe; RR 16.88, eclampsia). Conclusion: There is a strong association between α‐hCG and preeclampsia, nevertheless this test is unsuitable for predicting preeclampsia.

This publication has 7 references indexed in Scilit: